retatrutide type 2 diabetes phase 2 results 2024 2025 hits 28% weight loss in 3 Retatrutide, a TRIPLE agonist (GLP1,

Were looking to get them back in touch with their intuition around when theyre hungry, what theyre hungry for, and how they feel

Most patients start feeling the appetite-suppressing effects of a GLP-1 within the first few weeks of treatment, with measurable weight loss building over the following months

Chronic administration of exendin-4 or liraglutide has been shown to enhance hippocampal neurogenesis, reduce anxiety and depression-like behaviors, and attenuate neuroinflammatory cascades through downregulation of IL-6 and TNF- [63]

The six-month mark is also a good time for a full review with your provider

The more meaningful question is whether patients are preserving strength, lower body function, balance, mobility, and long term independence during weight loss

Jean-Gilles is dedicated to patient education and safety, ensuring you feel supported every step of the way